Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Comment on 'Ovarian Cancer: An ESMO Guide for Patients'

Dr Nicoletta Colombo - Istituto Europeo di Oncologia, Milan, Italy

Comment on 'Ovarian Cancer: An ESMO Guide for Patients' ( Dr Nicoletta Colombo - Istituto Europeo di Oncologia, Milan, Italy )

Editor’s Choice for September 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor’s Choice for September 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

A pilot study for the iManageCancer platform

Dr Chiara Renzi - European Institute of Oncology, Milan, Italy

A pilot study for the iManageCancer platform ( Dr Chiara Renzi - European Institute of Oncology, Milan, Italy )

iManageCancer clinical pilot design and preliminary outcomes

Dr Chiara Renzi - European Institute of Oncology, Milan, Italy

iManageCancer clinical pilot design and preliminary outcomes ( Dr Chiara Renzi - European Institute of Oncology, Milan, Italy )

Stephan Kiefer outlines the iManageCancer platform

Stephan Kiefer – Fraunhofer Institute for Biomedical Engineering IBMT, Sulzbach...

Stephan Kiefer outlines the iManageCancer platform ( Stephan Kiefer – Fraunhofer Institute for Biomedical Engineering IBMT, Sulzbach, Germany )

The breakthrough drug designation, patients driving progress

Dr Ellen V. Sigal - Friends of Cancer Research, Washington D.C., USA

The breakthrough drug designation, patients driving progress ( Dr Ellen V. Sigal - Friends of Cancer Research, Washington D.C., USA )

The 10th Anniversary of the WIN Consortium: lessons and perspectives

Dr Richard Schilsky - American Society Of Clinical Oncology, USA

The 10th Anniversary of the WIN Consortium: lessons and perspectives ( Dr Richard Schilsky - American Society Of Clinical Oncology, USA )

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Repurposing selective PDE5 inhibitors as anti-cancer agents

Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium

Repurposing selective PDE5 inhibitors as anti-cancer agents ( Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium )

The patient perspective for HARMONY

Tamas Bereczky - LeukaNet

The patient perspective for HARMONY ( Tamas Bereczky - LeukaNet )

Inequalities in immuno-oncology access across Europe

Dr Lydia Makaroff - European Cancer Patient Coalition, Brussels, Belgium

Inequalities in immuno-oncology access across Europe ( Dr Lydia Makaroff - European Cancer Patient Coalition, Brussels, Belgium )

Could personalised medicine increase inequality to medicine access?

Dr Stanimir Hasurdjiev - Bulgarian National Patients’ Organization, Sofia...

Could personalised medicine increase inequality to medicine access? ( Dr Stanimir Hasurdjiev - Bulgarian National Patients’ Organization, Sofia, Bulgaria )

More from ecancer